PureTech News

Press releases
Press Releases - 2023-12-22
Karuna
PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion
Continue
Press Releases - 2023-12-20
Internal Program - LYT-100
Other
PureTech Year End Update and Outlook for 2024
Continue
Press Releases - 2023-12-07
Gallop Oncology – LYT-200
PureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023
Continue
Press Releases - 2023-11-29
Karuna
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
Continue
Press Releases - 2023-11-17
Karuna
PureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia
Continue
Press Releases - 2023-11-14
Seaport
PureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy Volunteers
Continue
Press Releases - 2023-10-17
Other
PureTech to Present at Two Upcoming Investor Conferences
Continue
Press Releases - 2023-10-11
Internal Program - LYT-100
PureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual Meeting
Continue
Press Releases - 2023-10-04
Vedanta
PureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation
Continue
Press Releases - 2023-09-28
Karuna
KarXT, invented at PureTech, submitted for FDA Approval in Schizophrenia
Continue
Displaying 41 - 50 of 189

Sign up for email alerts

To receive news as it is released, please sign up.

@PureTechH